ITUA20162575A1 - Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa - Google Patents
Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essaInfo
- Publication number
- ITUA20162575A1 ITUA20162575A1 ITUA2016A002575A ITUA20162575A ITUA20162575A1 IT UA20162575 A1 ITUA20162575 A1 IT UA20162575A1 IT UA2016A002575 A ITUA2016A002575 A IT UA2016A002575A IT UA20162575 A ITUA20162575 A IT UA20162575A IT UA20162575 A1 ITUA20162575 A1 IT UA20162575A1
- Authority
- IT
- Italy
- Prior art keywords
- diseases
- pharmaceutical
- treatment
- disorders related
- polycystic ovary
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 201000010099 disease Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A002575A ITUA20162575A1 (it) | 2016-04-13 | 2016-04-13 | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
PL17727376T PL3452012T3 (pl) | 2016-04-13 | 2017-04-13 | Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych |
ES17727376T ES2890050T3 (es) | 2016-04-13 | 2017-04-13 | Composiciones para tratar el síndrome del ovario poliquístico y trastornos metabólicos relacionados |
PCT/IB2017/052151 WO2017179012A1 (en) | 2016-04-13 | 2017-04-13 | Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto |
HUE17727376A HUE055882T2 (hu) | 2016-04-13 | 2017-04-13 | Készítmény policisztás ovárium szindróma és ehhez kapcsolódó anyagcserezavarok kezelésére |
EP17727376.0A EP3452012B1 (en) | 2016-04-13 | 2017-04-13 | Compositions for treating polycystic ovary syndrome and related metabolic disorders |
US16/093,295 US11246834B2 (en) | 2016-04-13 | 2017-04-13 | Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto |
US17/583,051 US20220395460A1 (en) | 2016-04-13 | 2022-01-24 | Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUA2016A002575A ITUA20162575A1 (it) | 2016-04-13 | 2016-04-13 | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUA20162575A1 true ITUA20162575A1 (it) | 2017-10-13 |
Family
ID=56555565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUA2016A002575A ITUA20162575A1 (it) | 2016-04-13 | 2016-04-13 | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
Country Status (7)
Country | Link |
---|---|
US (2) | US11246834B2 (it) |
EP (1) | EP3452012B1 (it) |
ES (1) | ES2890050T3 (it) |
HU (1) | HUE055882T2 (it) |
IT (1) | ITUA20162575A1 (it) |
PL (1) | PL3452012T3 (it) |
WO (1) | WO2017179012A1 (it) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUA20162575A1 (it) | 2016-04-13 | 2017-10-13 | S&R Farm S P A | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
CN111655245B (zh) | 2017-11-23 | 2023-08-08 | 生物学研究院 | 提高患有多囊卵巢综合征的雌性受试者的胚胎着床率的方法 |
EP3810104B1 (en) * | 2018-04-16 | 2024-03-06 | S&R Farmaceutici S.p.A. | Mixture of resveratrol supported on magnesium hydroxide and non-supported pure resveratrol for treating female fertility |
IT201800011155A1 (it) * | 2018-12-17 | 2020-06-17 | S&R Farm S P A | uso di una miscela di berberina e resveratrolo per il controllo delle dislipidemie |
EP4000626A1 (en) * | 2020-11-16 | 2022-05-25 | concrete flowers GmbH | Pharmaceutical preparation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012107905A1 (en) * | 2011-02-10 | 2012-08-16 | Paladin Pharma S.P.A. | Composition for use in the treatment of menopause problems/disorders and in the treatment of general aging of the organism. |
WO2013076121A1 (en) * | 2011-11-22 | 2013-05-30 | Lo.Li. Pharma S.R.L. | Pharmaceutical composition comprising myo-inositol and d-chiro-inositol |
EP2875809A1 (en) * | 2013-11-26 | 2015-05-27 | Dicofarm Spa | Product based on an association of glucomannan and inositol |
IN2014MU01312A (it) * | 2014-04-09 | 2015-10-16 | Olive Healthcare |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20040395A1 (it) | 2004-08-03 | 2004-11-03 | Sigma Tau Ind Farmaceuti | Composizione comprendente statine e acidi grassi omega 3. |
US20100129467A9 (en) | 2007-08-31 | 2010-05-27 | Albritton Iv Ford D | Nutritional supplement |
US8383165B1 (en) | 2009-08-31 | 2013-02-26 | Fairhaven Health, Llc | Composition and method for fertility therapy using nutritional supplements |
US20130224281A1 (en) | 2011-04-07 | 2013-08-29 | United States Of America As Represented By The Administrator Of The National Aeronautics & Space | Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress |
ITPG20120030A1 (it) | 2012-06-27 | 2013-12-29 | Bernard Fioretti | Resveratrolo inorganico ibrido |
ITUB20153066A1 (it) * | 2015-08-11 | 2017-02-11 | Graal S R L | Composizione alimentare e/o nutraceutica contenente pea |
ITUA20162575A1 (it) | 2016-04-13 | 2017-10-13 | S&R Farm S P A | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
US10092545B2 (en) | 2016-04-30 | 2018-10-09 | Fairhaven Health, Llc | Nutritional supplements for improving female fertility |
EP3810104B1 (en) | 2018-04-16 | 2024-03-06 | S&R Farmaceutici S.p.A. | Mixture of resveratrol supported on magnesium hydroxide and non-supported pure resveratrol for treating female fertility |
-
2016
- 2016-04-13 IT ITUA2016A002575A patent/ITUA20162575A1/it unknown
-
2017
- 2017-04-13 US US16/093,295 patent/US11246834B2/en active Active
- 2017-04-13 PL PL17727376T patent/PL3452012T3/pl unknown
- 2017-04-13 ES ES17727376T patent/ES2890050T3/es active Active
- 2017-04-13 EP EP17727376.0A patent/EP3452012B1/en active Active
- 2017-04-13 WO PCT/IB2017/052151 patent/WO2017179012A1/en unknown
- 2017-04-13 HU HUE17727376A patent/HUE055882T2/hu unknown
-
2022
- 2022-01-24 US US17/583,051 patent/US20220395460A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012107905A1 (en) * | 2011-02-10 | 2012-08-16 | Paladin Pharma S.P.A. | Composition for use in the treatment of menopause problems/disorders and in the treatment of general aging of the organism. |
WO2013076121A1 (en) * | 2011-11-22 | 2013-05-30 | Lo.Li. Pharma S.R.L. | Pharmaceutical composition comprising myo-inositol and d-chiro-inositol |
EP2875809A1 (en) * | 2013-11-26 | 2015-05-27 | Dicofarm Spa | Product based on an association of glucomannan and inositol |
IN2014MU01312A (it) * | 2014-04-09 | 2015-10-16 | Olive Healthcare |
Non-Patent Citations (3)
Title |
---|
ANONYMOUS: "Female infertility but not only... discover the polycystic ovary syndrome", S&R FARMACEUTICI NL|10 - 28 JUNE 2016, 28 June 2016 (2016-06-28), XP055325540, Retrieved from the Internet <URL:http://www.srfarmaceutici.it/nl10-28-june-2016/?lang=en> [retrieved on 20161202] * |
DATABASE EPODOC [online] EUROPEAN PATENT OFFICE, THE HAGUE, NL; XP002765077, Database accession no. IN-1312MU2014-A * |
DATABASE WPI Week 201601, Derwent World Patents Index; AN 2015-662344, XP002765076 * |
Also Published As
Publication number | Publication date |
---|---|
PL3452012T3 (pl) | 2022-01-24 |
EP3452012B1 (en) | 2021-06-23 |
WO2017179012A1 (en) | 2017-10-19 |
US20220395460A1 (en) | 2022-12-15 |
HUE055882T2 (hu) | 2021-12-28 |
ES2890050T3 (es) | 2022-01-17 |
US11246834B2 (en) | 2022-02-15 |
EP3452012A1 (en) | 2019-03-13 |
US20190125675A1 (en) | 2019-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3616720T3 (da) | Farmaceutisk sammensætning til cancerbehandling | |
SV2018005610A (es) | Derivados de oxopiridina sustituidos | |
DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
DK3253382T3 (da) | Farmaceutiske sammensætninger til kombinationsterapi | |
IL255109A0 (en) | New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders | |
ES2969758T3 (es) | Composiciones farmacéuticas para usar en la terapia de la blefaritis | |
SV2018005775A (es) | Forma polimorfa de n-{6-(2-hidroxipropan-2-il)-2-[2-(metilsulfonil)etil]-2h-indazol-5-il}-6-(trifluorometil)piridin-2- carboxamida | |
CL2015002767A1 (es) | Compuestos terapéuticos y composiciones | |
ITUA20162575A1 (it) | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa | |
DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
UY35746A (es) | Derivados de fenilalanina sustituidos | |
DK3129057T3 (da) | Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi | |
IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. | |
CL2016002321A1 (es) | Compuestos derivados del ácido 2-8-5-cloropirimidin-2-ilamino-6,7,8,9-tetrahidro-5h-pirido3,2-bindol-5-ilacético, moduladores del receptor de prostaglandina d2 composición farmacéutica y su uso para el tratamiento de enfermedadestrastornos alérgicosinmunitarios. | |
IT201600121617A1 (it) | Composizione per il trattamento del reflusso gastroesofageo | |
IT201600130012A1 (it) | Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale | |
UY35610A (es) | Derivados de prodroga de triazolpiridinas sustituidas | |
DK3369429T3 (da) | Farmaceutisk sammensætning tiltænkt at blive administreret til næseslimhinden | |
CL2019000027A1 (es) | Regímenes de dosificación de antagonistas de la lingo-1 y usos para el tratamiento de los trastornos desmielinizantes. | |
IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori | |
DOP2016000325A (es) | Compuestos, composición farmacéutica y su uso en el tratamiento de enfermedades neurodegenerativas | |
ITUA20163025A1 (it) | Composizione per il trattamento della sindrome dell’ovaio policistico | |
CL2016001054A1 (es) | Compuestos para el tratamiento de diabetes y complicaciones de enfermedades derivadas de la misma | |
ITUB20169928A1 (it) | Formulazioni farmaceutiche per il trattamento del diabete |